Search

The article discusses about medical marijuana and its legalization in 23 U.S. states and in the District of Columbia. It states that medical marijuana can be used on several medical conditions which include glaucoma, multiple sclerosis (MS), and nausea on patients undergoing into chemotherapy. A graph which shows the estimated increase retail sales of marijuana in the U.S. by 2020, are provided.

The article looks at nine significant issues that glaucoma patients should know about the ocular disease. Topics mentioned include a study that looked at patients diagnosed between 1981 and 2000 compared with patients diagnosed between 1965 and 1980 in the same geographic location, the best treatments for glaucoma, and blurred vision or vision loss caused by angle closure glaucoma.

The article presents information on how to physicians can handle the queries of patients with glaucoma regarding the progressive disease will affect their everyday living. Topics discussed include the treatment and quality-of-life expectations, the therapeutic options like selective laser trabeculoplasty (SLT) and filtration surgery, and the presciption of marijuana.

The article discusses the story of glaucoma patient Robert C. Randall's successful fight to get marijuana legally from the U.S. federal government to treat his disease. Randall was diagnosed by an ophthalmologist of having glaucoma in 1972. In 1975, he was charged by the government for cultivating marijuana in his apartment in Washington, D.C. He used the research of Robert Hepler about clinical trials on marijuana and glaucoma in his defense. In November 1976, Randall received his first supplies of marijuana from the government. INSET: THE PHARMACIST'S CHALLENGE.

The article looks at some glaucoma treatment alternatives, which may expand beyond surgery, medication, and lasers. They include marijuana, ginkgo, and memantine. Also mentioned are acupuncture, meditation, perfusion pressure, and other supplements such as black currant, Mirtogenol tablets, and palmitoylethanolamide.

Cites a study which claimed that smoking marijuana is neither an effective nor a safe method of lowering IOP in glaucoma patients. Key findings of the report by researcher Keith Green; Health hazards of marijuana; Cognitive effects induced by marijuana; Movement to legalize use of marijuana for health reasons.

Focuses on the initiatives taken by the U.S. government to market Delta-9-Tetrahydrocannabinol (THC), the active ingredient in marijuana. Use of THC in the treatment of glaucoma and the spasms associated with multiple sclerosis; Complications associated with the attributes of THC; Importance of marijuana to the cancer patients.

The article focuses on the approval given to the use of marijuana for the treatment of certain medical conditions, like glaucoma in California in 1996.

The article discusses the different truths and myths about medical marijuana. Topics covered include how the recreational use of marijuana in small quantities is legal in Colorado and Washington. Also mentioned are the adverse effects to using medical marijuana like respiratory and cardiovascular problems and the proper administration of medical marijuana.

Reports on the findings by Kieth Green of the Medical College of Georgia in Augusta, Georgia which indicates that marijuana eye drops may be the most effective method of treating the glaucoma. Request made by a drug company to the U.S. Food and Drug Administration for permission to test the treatment on humans.

The article explores the potential of marijuana as a treatment for glaucoma. It is stated that since 1971, there has been many studies concluding that active agents in marijuana are able to lower intraocular pressure in normal subjects and glaucoma patients. However, there were no studies published regarding long-term ocular and systemic effects of the plant used by glaucoma patients.